Je was op zoek naar: ua (Engels - Maltees)

ru/ua
ru/ukr

ukraine= ua
l-ukrajna = ua

ro/md/ua
ro/md/ukr

zilina – ua border
fruntiera zilina – ua

budapest-miskolc-ua border
budapest-miskolc-fruntiera tal-ua

gdynia, the other hub e br ua ri f
gdynia, iċ-ċentru l-ieħor

ua/ nstemi primary composite outcome events
ua/ nstemi avvenimenti primarji komposti li seħħew

recommendations for the work of ua partnerships and the participation process
rakkomandazzjonijiet għall-ħidma tas-sħubijiet tal-aġenda urbana u l-proċess tal-parteċipazzjoni

10,057 patients undergoing treatment of ua or nstemi acs
10,057 pazjenti li qed jirċievu trattament għal ua jew nstemi acs

all patients received standard medical treatment for ua/ nstemi,
il- pazjenti kollha ġew mogħtija trattament mediku normali għal ua/ nstemi, bi 34% minnhom operati b’ pci u 9% minnhom b’ cabg.

1.6 to ensure effective implementation of the new eu ua it is necessary:
1.6 sabiex tiġi żgurata l-implimentazzjoni effettiva tal-aġenda urbana l-ġdida tal-ue, jeħtieġ li:

bleeding was a commonly reported event in patients with ua/nstemi and stemi.
l-effett ta’ fsada ġie rrappurtat komunement f’pazjenti b’ua/nstemi u stemi.

patients had acs with moderate to high risk ua, nstemi, or stemi and were managed with pci.
il- pazjenti kellhom acs b' ua, nstemi, jew stemi ta 'riskju moderat jew għoli u ġew ittrattati b' pci.

prevention of vte and treatment of ua/nstemi and stemi - dosing adjustment of fondaparinux is not necessary.
prevenzjoni ta’ vte u kura ta’ ua/nstemi u stemi - mhux neċessarju li jsir aġġustament fid- doża ta’ fondaparinux.

in the pivotal ua/nstemi clinical trial, treatment with fondaparinux was restarted no earlier than 2 hours after sheath removal.
fil-prova klinika pivotali ua/nstemi, trattament b’fondaparinux reġa’ nbeda mhux aktar kmieni minn sagħtejn wara li tneħħiet ix-sheath.

ut treatment of unstable angina or non-st segment elevation myocardial infarction (ua/ nstemi)
pr

incidences in non-primary pci in ua/nstemi were 1.0% vs 0.3% (fondaparinux vs. enoxaparin) and in primary pci in stemi were 1.2% vs 0% (fondaparinux vs. control).
l-inċidenzi f’pci mhux primarju f’ua/nstemi kienu ta’ 1.0% kontra 0.3% (fondaparinux kontra enoxaparin) u f’pci primarju f’stemi kienu ta’ 1.2% kontra 0% (fondaparinux kontra l-kontroll).